IDEXX LABORATORIES INC /DE — Director's Dealing 2018

Jan 3, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2018-01-01

Reporting Person: MCKEON BRIAN P (Executive VP & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-01-01	Common Stock	M	2820	—	Acquired	41533	Direct
2018-01-01	Common Stock	F	1095	$156.38	Disposed	40438	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-01-01	Restricted Stock Unit	$	M	2820	Disposed		Common Stock (2820)	Direct

Footnotes

F1: Includes a total of 165 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2017, June 30, 2017, September 29, 2017 and December 29, 2017.

F2: Closing price of Issuer's common stock on the NASDAQ market on December 29, 2017.

F3: These restricted stock units are part of a grant made to the reporting person on January 1, 2014 that have vested. Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary of the date of grant. The number of restricted stock units reported was adjusted to reflect a 2-for-1 stock split in the form of a 100% stock dividend on IDEXX Laboratories, Inc. common stock paid on June 15, 2015.

F4: Not applicable.